Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Observational 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Carcinoma, Hepatocellular 20Carcinoma, Renal Cell 16Liver Neoplasms 7Leukemia, Myeloid, Acute 3Thyroid Neoplasms 2Financial Stress 2Carcinoma 2Patient Preference 1Neuroendocrine Tumors 1Neoplastic Cells, Circulating 1Kidney Neoplasms 1Colorectal Neoplasms 1Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies 1Carcinoma, Non-Small-Cell Lung 1COVID-19 1Adenoma, Islet Cell 1

Interventions

Surveys and Questionnaires 3pazopanib 2Sunitinib 2Sorafenib 2Bevacizumab 2Patient Reported Outcome Measures 1Medical Records 1Data Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Financial Stress × Sorafenib × Clear all
NCT01381601 2013-05-13

Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (Pharmetrics)

GlaxoSmithKline

Completed
1 enrolled
Genitourinary

Financial Stress, Carcinoma, Renal Cell

NCT01381614 2013-05-13

Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (IHCIS)

GlaxoSmithKline

Completed
1 enrolled
Genitourinary

Financial Stress, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡